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ABREVIATIONS 
HIT – High intensity interval training 
MICT – Moderate intensity continuous training 
CON – Control day of no exercise 
aPWV – Aortic pulse wave velocity 
CGMS – Continuous glucose monitoring system 
CHO - Carbohydrate 
SBP – Systolic blood pressure 
DBP – Diastolic blood pressure 
MAP – Mean arterial pressure 
EXTOD – Exercising for type 1 diabetes 
V& O2max – Aerobic capacity 
Wmax – Maximal power output 
V& O2peak - Peak oxygen consumption 
IMTG - Intramuscular triglyceride 
AIMS – To investigate whether 1) six weeks of high-intensity interval training (HIT) induces 
similar improvements in cardio-metabolic health markers as moderate-intensity continuous 
training (MICT) in people with type 1 diabetes, and 2) whether HIT abolishes acute 
reductions in plasma glucose observed following MICT sessions. 
METHODS – Fourteen sedentary individuals with type 1 diabetes (n=7 per group) 
completed six weeks of HIT or MICT 3 times per week. Pre- and post-training measurements 
were made of 24h interstitial glucose profiles (using continuous glucose monitors (CGMS)) 
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and cardio-metabolic health markers (V& O2peak, blood lipid profile and aortic pulse wave 
velocity; aPWV). Capillary blood glucose concentrations were assessed before and after 
exercise sessions throughout the training programme to investigate changes in blood glucose 
during exercise in the fed state.  
RESULTS – Six weeks of HIT or MICT increased V& O2peak by 14% and 15%, respectively 
(P<0.001), and aPWV by 12% (P<0.001), with no difference between groups. 24h CGMS 
data revealed no differences in incidence or percentage of time spent in hypoglycaemia 
following training in either group (P>0.05). In the fed state, the mean change in capillary 
blood glucose concentration during the HIT sessions was -0.2±0.5 mmol/L, whereas blood 
glucose change was -5.5±0.4 mmol/L during MICT. 
CONCLUSIONS - Six weeks of HIT improved V& O2peak and aortic PWV to a similar extent 
as MICT. The finding that blood glucose remained stable during HIT in the fed state, but 
consistently fell during MICT, suggests that HIT may be the preferred training mode for 
some people with type 1 diabetes.  
HIGH-INTENSITY INTERVAL TRAINING IMPROVES AEROBIC CAPACITY AND ABOLISHES THE 
DECLINE IN BLOOD GLUCOSE OBSERVED DURING MODERATE-INTENSITY CONTINUOUS 
TRAINING SESSIONS IN PEOPLE WITH TYPE 1 DIABETES. 
INTRODUCTION 
Regular exercise is recommended for people with type 1 diabetes to maintain overall health 
and reduce the risk of macrovascular and microvascular complications, which are a major 
cause of mortality and morbidity1,2. The current guidelines for people with type 1 diabetes are 
to undertake at least 150 minutes of moderate to vigorous aerobic exercise per week, spread 
over at least three days per week, with no more than two consecutive days without activity3. 
Benefits of exercise for those with type 1 diabetes include improved aerobic capacity (V&
O2max), insulin sensitivity, body composition, endothelial function and blood lipid profile1,4-6. 
Despite the benefits, few people with type 1 diabetes achieve exercise targets and many 
programmes designed to increase physical activity have failed7,8. In addition to the barriers to 
exercise cited by the general population, such as a perceived lack of time, work commitments 
and cost9, people with type 1 diabetes face additional barriers including fear of 
hypoglycaemia, loss of glycaemic control and inadequate knowledge around exercise 
management10,11.  
 To overcome a perceived lack of time, high intensity interval training (HIT) is 
purported as a time-efficient alternative to moderate-intensity exercise to improve numerous 
cardio-metabolic risk factors includingV& O2max, insulin sensitivity and glycaemic control in 
people without type 1 diabetes12,13. Furthermore, results from our laboratory show that a 
single bout of HIT does not increase the risk of hypoglycaemia in people with type 1 diabetes 
(Scott et al. unpublished observations, see supplementary material14). Whether HIT offers a 
safe, effective and time-efficient training strategy to improve cardio-metabolic health that 
reduces the risk of hypoglycaemia in people with type 1 diabetes is yet to be investigated.  
Here we investigated the hypothesis that six weeks of HIT would improve markers of 
cardio-metabolic health, including V& O2peak, glycaemic control, blood lipid profile and 
vascular health in people with type 1 diabetes. A moderate intensity continuous training 
(MICT) group was used as a control. During this 6-week training period capillary blood 
glucose concentrations were monitored before and after exercise sessions to provide further 
information on the acute effects of HIT and MICT on blood glucose concentration.  
RESEARCH DESIGN AND METHODS 
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Fourteen previously sedentary people with type 1 diabetes (10 men/4 women; see Table 1 for 
participant characteristics) on a basal-bolus insulin regimen completed six weeks of 
supervised HIT (n=7) or MICT (n=7) three times per week. Participants were pair-matched 
based on sex, age and V& O2peak to the two training groups. Exclusion criteria were duration of 
type 1 diabetes <6 months, insulin pump therapy, poor diabetes control (HbA1c >86 
mmol/mol), frequent hypoglycaemia (>5 per week) and/or hypo-unawareness (determined 
from medical history), obesity (BMI >30 kg·m-2), pregnancy or planning pregnancy, 
uncontrolled hypertension (>180/100 mmHg), angina, autonomic neuropathy, taking any 
medication that affects heart rate, major surgery planned within 6 weeks of the study, severe 
nonproliferative and unstable proliferative retinopathy. Testing took place in the laboratory of 
the School of Sport and Exercise Sciences at Liverpool John Moores University. The study 
was approved by the Black Country NHS Research Ethics Committee (West Midlands, UK) 
and all participants gave written informed consent to a protocol conforming to the 
Declaration of Helsinki.  
Pre-training assessments 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, The 
Netherlands) to determine maximal aerobic power output (Wmax) and V& O2peak using an online 
gas collection system (MOXUS modular oxygen uptake system, AEI technologies, 
Pittsburgh, PA). The test consisted of 3-minute stages starting at 60 W, and the workload was 
increased by 35 W at each stage until subjects could not maintain a cadence of >50 rpm, at 
which point the test was terminated. V& O2peak was taken as the highest value achieved over a 
15 second recording period.  Participants also completed a food diary over a minimum of 
three days in order to calculate habitual caloric and macronutrient intake. 
Three to 7 days after the incremental exercise test, participants attended the laboratory 
after an overnight fast (>10 h) for a second pre-training assessment session. Following 15 
minutes rest, supine brachial artery blood pressure measurements were made in triplicate 
using an automated sphygmomanometer (GE DINAMAP Pro 300 V2). Aortic pulse wave 
velocity (aPWV) measurements were made using a semi-automated device and software 
(SphygmoCor, AtCor Medical, Sydney, Australia), as previously described by Cocks et al.15. 
A fasting blood sample was used to determine fasting plasma cholesterol and triglyceride 
concentrations, using a semi-automatic spectrophotometer (Randox RX Daytona™, County 
Antrim, UK).  
A Dexcom G4 Platinum (Dexcom, San Diego, CA, USA) CGMS probe was inserted 
subcutaneously into the abdomen. A habitual free-living 24h glucose profile was analysed at 
least 24 hours after the CGMS was inserted. Participants were trained to use the CGMS and 
instructed to calibrate the device a minimum of four times daily using capillary blood tests. 
Participants were provided with a standardised diet of three meals (breakfast, lunch and 
dinner) during the CGMS period (50% CHO; 30% fat; 20% protein) in accordance with their 
habitual calorie intake. Participants were instructed to consume these meals at pre-determined 
time points throughout the day. No additional snacks were permitted and participants only 
consumed the food provided by the research team during this period, unless they needed to 
prevent hypoglycaemia (blood glucose <3.0 mmol/L)16. A food diary was completed to 
confirm that they had consumed the prescribed food at the correct times. Participants were 
instructed to avoid alcohol and caffeine, as well as exercise throughout the CGMS period.  
Exercise Training  
Training started ~72h after completion of the pre-experimental procedures. Participants 
trained three times per week for six weeks under researcher supervision on a Lode Corival 
cycle ergometer (Corival Lode BV, Groningen, The Netherlands). Following a 3-minute 
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low-intensity warm-up, the HIT group performed repeated 1-minute bouts of high intensity 
cycling at a workload equivalent to 100% V& O2peak interspersed with 1 minute of recovery at 
50 W, whereas the MICT group performed continuous moderate intensity cycling at a 
workload equivalent to 65% V& O2peak. The number of intervals in the HIT group increased 
from 6 in weeks 1 and 2, to 8 in weeks 3 and 4 to 10 in weeks 5 and 6. The duration of the 
sessions in the MICT group were 30 minutes in weeks 1 and 2, 40 minutes in weeks 3 and 4 
and 50 minutes in weeks 5 and 6. 
Acute change in blood glucose with exercise 
Participants were able to attend their training session between 7am and 5pm Monday to 
Friday. The amount and type of food was not controlled but we asked participants not to fast 
before exercising and not to exercise within 30 minutes of a meal with the aim being to study 
the effects of HIT and MICT under ‘real world’ conditions. Therefore, these training sessions 
are defined as being in the ‘fed’ state in this investigation. In line with advice that has been 
used in other studies17, and in keeping with international agreed advice18, if patients were 
doing MICT within 2 hours of a meal they were asked to reduce their fast acting insulin at 
that meal by 50%. No adjustments were made if doing a HIT session. Before starting and 
after completing each training session during the six-week training period, participant’s blood 
glucose concentrations were required to be between 7-14 mmol/L.  If blood glucose 
concentrations fell outside of this range corrective measures were taken; glucose was ingested 
if blood glucose <7 mmol/L, and a light walk or insulin bolus was advised if glucose >14 
mmol/L, as well as checking blood ketones. In addition, when they first started exercising 
they were asked to check their glucose at 2am and to reduce their night time background 
insulin by 10%. Reduction of insulin at night could be continued if the participant found that 
their glucose was going low overnight on the day of exercise. All participants were asked to 
measure their blood glucose before and after an exercise session, in addition participants in 
the MICT arm were advised to check their blood glucose part-way through the exercise and 
to consume carbohydrate as necessary to prevent hypoglycaemia. Over the course of the 6 
weeks of training we gathered pre and post-exercise blood glucose concentrations from a 
total of 108 (86%) MICT training sessions and 87 (69%) HIT sessions. 
Post-training assessments 
Approximately 72h after the final training session, participants attended the laboratory on two 
occasions (separated by 72h) to complete a series of post-training assessments.  These 
assessments were identical in all respects to those undertaken prior to training (pre-training 
assessments).   
Statistical analyses 
The primary outcome variable to measure a significant training benefit was V& O2peak. 
Previous research in our group17,19 has suggested a SD of 2.7-3.2 to detect a change in V&
O2peak of 3.5 ml·kg-1·min-1, which is a clinically significant increase in V& O2peak20. A power 
calculation suggested that 7-9 participants were required in each group to detect a within-
group difference with a paired t test with 80% power at a significance level of 0.05. 
Continuous glucose monitor data were downloaded from the device using Dexcom Studioᵀᴹ 
software (12.0.4.6) and analysed in accordance with the International Consensus on Use of 
Continuous Glucose Monitoring21. Glycaemic thresholds were defined as follows: target 
range (3.9-10 mmol/L), level 1 hypoglycaemia (≤3.9 mmol/L), level 2 hypoglycaemia (≤2.9 
mmol/L) and hyperglycaemia (≥10 mmol/L). The 24h period was defined as 08:00-08:00h 
and the nocturnal period was defined as 24:00-06:00h. All variables were analysed using a 
two-way mixed ANOVA, with the between factor ‘group’ (HIT vs. MICT) and repeated 
factor ‘training status’ (pre-training vs. post training), followed by Bonferroni post-hoc 
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corrections. A two way mixed ANOVA, with the between factor ‘group’ and the repeated 
factor ‘time point’ (pre-training vs. post training) was used to assess whether there was an 
acute change in blood glucose concentration following HIT and MICT in the fed state over 
the 6 weeks of training. The CGMS did not work on one participant in the MICT group. 
Aortic PWV readings were obtained from five participants in the HIT group and six in the 
MICT group. All analyses were performed using IBM SPSS Statistics for Windows, Version 
22.0. Armonk, NY: IBM Corp. Data are presented as mean ± SEM and significance was set 
at P≤0.05. 
RESULTS 
By design, there were no differences in age (P=0.877), V& O2peak (P=0.371) or duration of type 
1 diabetes (P=0.291) between the training groups at baseline. BMI was, however, 
significantly higher in the HIT group compared to the MICT group (P=0.038). Pre and post-
training variables are presented in Table 1. Training increased V& O2peak (HIT 14%, MICT 
15%; P<0.001) and Wmax (HIT 13%, MICT 14%; P<0.001), with no difference between 
groups (Fig. 1). Six weeks of training also improved aPWV (P=0.001) and there was no 
difference between groups. Systolic, diastolic and mean arterial blood pressure did not 
improve following training (P=0.219; P=0.476; P=0.268, respectively). There was no change 
in plasma cholesterol or triglyceride concentrations with training (P=0.881; P=0.652, 
respectively). 
Glycaemic control 
Glucose data from the CGMS obtained over a 24h period pre- and post-training are presented 
in Table 2. There was no difference in the time spent in level 1 hypoglycaemia (≤3.9 
mmol/L) over the 24h period (P=0.727) or nocturnal period (P=0.289) with training. 
Similarly, there was no difference in time spent in level 2 hypoglycaemia (≤2.9 mmol/L) with 
training over the 24h period (P=0.442) or nocturnal period (P=0.397). There were also no 
differences in the time spent in target range over the 24h (P=0.412) or nocturnal periods 
(P>0.382). Furthermore, there was no difference in the time spent in hyperglycaemia over the 
24h (P=0.540) or nocturnal period (P=0.118). However, there was an interaction effect for 
the time spent in target range (P=0.034) and time in hyperglycaemia over the nocturnal 
period (P=0.039). Post hoc analysis revealed that the HIT group spent significantly less time 
in target glycaemia during the nocturnal period (P=0.038) which was due to a greater time 
spent in hyperglycaemia over the nocturnal period (P=0.016). The incidence of level 1 
hypoglycaemia over the 24h period (P=0.675) and nocturnal period (P=0.363) was no 
different before and after HIT or MICT. There were no differences in the incidence of level 2 
hypoglycaemia over the 24h (P=0.174) or nocturnal (P=0.549) period following 6 weeks of 
HIT or MICT.  
Acute change in blood glucose during training sessions  
When quantifying the change in blood glucose concentration during exercise training 
sessions undertaken in the fed state over the six-week intervention, the mean change in blood 
glucose concentration in response to HIT was -0.2 ± 0.5 mmol/L (P<0.001) whereas blood 
glucose decreased by -5.5 ± 0.4 mmol/L in response to MICT (P=0.626; Fig. 2). 
DISCUSSION 
This study demonstrates for the first time that six weeks of HIT improves V& O2peak and aPWV 
in people with type 1 diabetes to a similar magnitude as MICT. Secondly, we observed that 
blood glucose concentration remained stable during the HIT sessions performed in the fed 
state throughout the training programme, but there was a consistently large drop in blood 
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glucose during MICT throughout the training programme, with participants at risk of 
hypoglycaemia. The CGMS data revealed that 24 hour glucose was not affected by either 
form of training. However, overnight there was a decrease in the time spent in target range in 
the HIT group, due to an increase in time spent in hyperglycaemia, while there were no 
changes in glycaemic control in the MICT group. The fact that HIT is a time-efficient 
training mode that improved V& O2peak and aPWV to a similar extent as MICT but did not 
cause a fall in glucose during exercise as was observed during MICT means that it may be a 
more practical exercise strategy for some patients with type 1 diabetes. However, the increase 
in nocturnal hyperglycaemia following HIT is of concern and suggests that people with type 
1 diabetes may have to reduce their carbohydrate intake prior to and/or following HIT 
sessions or make changes to their night-time background insulin to prevent high glucoses 
overnight.  
Aerobic capacity improved to a similar extent following six weeks of HIT and MICT, 
despite the weekly time commitment being 54-90 minutes less for HIT than for MICT. The 
14% increase in V& O2peak observed in our investigation following HIT (a mean increase of 4.9 
ml·kg-1·min-1) is high in comparison to other studies using similar protocols that tend to 
report changes of 7-10% in populations without type 1 diabetes22 and the only other study to 
examine the effect of sprint interval training in people with type 1 diabetes (repeated 30-
second maximal cycling bouts interspersed with 3-4 minutes of rest 3 times a week for 7 
weeks) reported a 7% increase in V& O2peak23. This has clinical importance given that V& O2max 
is reported to be the strongest prognostic marker of cardiovascular mortality20 and 
improvements in  V& O2max with exercise training are associated with a reduction in all-cause 
mortality risk24. In fact, Myers20 found that there is a 8-17% reduction in all-cause mortality 
for each 1-MET (~3.5 ml·kg-1·min-1) increase in V& O2max. Although these correlations have 
not been specifically confirmed in people with type 1 diabetes, it is likely that the HIT 
programme used here induces clinically meaningful benefits to this population, which is 
especially important as they are at increased risk of cardiovascular disease compared to a 
non-diabetic population1,2.  
In the present study there was a 12% reduction in aPWV following both training modes, 
which is greater than has previously been reported in other training studies in populations 
without type 1 diabetes25,26. To the authors’ knowledge, this is the first study to investigate 
changes in arterial stiffness following HIT and MICT in people with type 1 diabetes. The 
reduction in aPWV is of clinical relevance as increased arterial stiffness is associated with 
negative cardiovascular outcomes27.  
Neither training mode improved glycaemic control according to the CGMS data, 
measured as time spent in target range (euglycaemia) or hypoglycaemia or the incidences of 
hypoglycaemia. Previous studies using HbA1c and daily insulin dosage as a marker of 
glycaemic control have also failed to show overall improvements in glycaemic control with 
exercise training23,28,29, although studies reporting positive effects of training on glycaemic 
control do exist30. There was a reduction in the time spent in euglycaemia overnight in the 
HIT group which was due to an increase in the time spent in hyperglycaemia. Although 
increasing the proportion of time spent in hyperglycaemia during the nocturnal period is not 
desirable, it did reduce the risk of developing hypoglycaemia which may mean that HIT is a 
preferable form of training for those concerned about hypoglycaemia during exercise. The 
increased time spent in hyperglycaemia overnight with HIT is concerning, given that this will 
increase the risk of long term complications so needs to be explored further in the future. 
There are three potential reasons for this rise in glycaemia with HIT. Firstly, due to an 
increase in adrenaline and noradrenaline post exercise. However, although this may explain 
the higher glucose levels just after exercise, this is unlikely to explain the higher nocturnal 
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glycaemia as these hormones fall rapidly after cessation of exercise. This is further supported 
by another study performed in our laboratory (Scott et al. under review in JCEM), that used 
CGMS to show that an acute bout of HIT did not increase glucose post exercise or in the 
overnight period. A second reason may be that participants consumed too much carbohydrate 
in the HIT condition as the total workload of HIT is less than MICT meaning that less 
glucose is removed from the blood to replenish muscle and liver glycogen stores. Thirdly, 
there may have been inadequate background insulin overnight. At the start of training, 
participants were asked to reduce their overnight background insulin by 10%. Thereafter, 
whether they did this was dependent on their blood glucose concentration before they went to 
bed, their blood glucose on the previous days after training, and how concerned they were 
about going low overnight. It may be that participants reduced their overnight background 
insulin when this was not required. Unfortunately, we did not record their insulin dosages so 
do not know if this happened. Although the use of CGMS in our investigation allowed a 
detailed analysis of glycaemic control, we acknowledge that longer duration exercise training 
programmes with larger sample sizes are needed to assess the effects of exercise training on 
long-term glycaemic control. Furthermore, the current guidelines suggest that a minimum of 
14 consecutive days should be recorded when analysing CGMS data21. Unfortunately, these 
guidelines were published after our data collection was completed so will be used in future 
studies. 
Before the training sessions, we recorded blood glucose concentration for safety reasons 
to prevent participants from exercising when glucose concentrations were too high or low 
based on the EXTOD guidelines31. Blood glucose was also recorded after the sessions so that 
participants did not leave the laboratory while they were potentially at increased risk of 
hypoglycaemia. This meant that we collected pre and post-exercise blood glucose readings 
from up to 18 training sessions for each participant over the course of six weeks of HIT or 
MICT. We collected pre and post-exercise blood glucose concentrations from a total of 108 
(86%) MICT training sessions and 87 (69%) HIT sessions. During the HIT sessions glucose 
remained stable throughout the training programme whereas during MICT sessions there was 
a consistently large fall in glucose. This was a consistent observation across all participants 
undertaking MICT (Fig. 2b). Readings from at least 9 sessions were available for every 
participant and the clear differences between the groups and the low standard deviation for 
the changes in blood glucose suggest the results were not affected by the different number of 
readings per group. The changes in blood glucose concentration during the exercise reported 
here are striking and are the first of their kind in the literature over so many training sessions. 
Furthermore, they are supported by Garcia-Garcia et al.32 who conducted a systematic review 
and meta-analysis in which they aggregated results from 10 studies to estimate rate of change 
of glucose concentration during and after different types of exercise in people with type 1 
diabetes. Their results showed a rapid decline in glycaemia during continuous exercise (-4.43 
mmol/L h-1 on average) while the results were more variable during intermittent high 
intensity exercise depending on the protocol.  
The drop in blood glucose concentration during the MICT sessions is likely due to the 
effects of short-acting insulin in the circulation. In healthy individuals, blood glucose 
concentration remains stable during moderate-intensity aerobic exercise because insulin 
secretion is suppressed progressively with exercise duration and there is a gradual increase in 
glucagon and adrenaline resulting in increased hepatic glucose production33,34. Therefore, 
contraction-mediated glucose uptake is matched by increased hepatic glucose production so 
that blood glucose concentration remains stable at ~4.0-6.0 mmol/L33. However, as insulin is 
supplied exogenously in people with type 1 diabetes, hyperinsulinaemia is likely to occur 
because of increased blood flow and mobilisation of insulin from its subcutaneous depot, 
particularly if the injection site is in an exercised region33. This results in enhanced glucose 
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uptake due to combined contraction-mediated and insulin-stimulated GLUT4 translocation. 
The high insulin levels will also suppress the exercise-mediated increases in glucagon and 
adrenaline and their ability to stimulate hepatic glucose production35. As a result, muscle 
glucose uptake during MICT will exceed hepatic glucose production, leading to the large 
decreases in plasma glucose concentration observed in this study (Fig. 2). Hyperinsulinaemia 
has also been shown to suppress adipose tissue and intramuscular triglyceride (IMTG) 
lipolysis in healthy individuals36, which will reduce the contribution of lipids to the fuel 
mixture oxidised during exercise. The combination of insulin and exercise-mediated glucose 
disposal coupled with decreased hepatic glucose production and reduced lipolysis and lipid 
oxidation increases the risk of hypoglycaemia during MICT. On the other hand, the stable 
blood glucose concentrations following HIT are likely due to greater plasma catecholamine 
(particularly noradrenaline) concentrations which lead to an increase in hepatic glucose 
production, thus offsetting the effects of hyperinsulinaemia37. Previous research has shown 
that addition of a sprint to a bout of moderate-intensity exercise in individuals with type 1 
diabetes opposed the fall in glycaemia during exercise and this was associated with a rise in 
catecholamines38. Following a bout of HIT, it may be speculated that the greater 
catecholamine response compared to MICT may lead to stimulation of adipose tissue 
lipolysis and increase oxidation of the released fatty acids in the muscle during recovery39.  
Another important observation, although not quantitatively reported here, was the number 
of training sessions in which participants had to prevent or treat an episode of hypoglycaemia 
by consuming fast-acting carbohydrate. During the MICT sessions, participants were advised 
to stop exercising at least once to check their blood glucose concentration in accordance with 
the EXTOD guidelines31, correct accordingly with glucose if necessary, and then wait for 
their blood glucose to stabilise before recommencing the training. Many of the participants in 
the MICT condition found this frustrating and it would often mean that the already time 
consuming 50-minute cycling sessions were even longer while blood glucose was checked. 
The large drop in blood glucose concentration that we found during the MICT sessions 
highlights why the guidelines recommend that carbohydrate should be taken when doing 
more than 30 minutes of moderate-intensity exercise40. Therefore, these findings provide 
evidence that HIT may be a more practical form of exercise for people with type 1 diabetes 
that regularly experience problems with hypoglycaemia during exercise.  
The main strengths of this investigation were 1) the strict dietary standardisation under 
free-living conditions during the CGMS period pre and post-training, and 2) the monitoring 
of acute changes in blood glucose concentrations during exercise throughout the intervention. 
We also acknowledge that there are some limitations. The sample size of the study was small; 
however, the clear significant increases in V& O2peak suggest that we have the power to 
conclude that HIT is effective at improving V& O2peak in people with type 1 diabetes. Secondly, 
we did not record insulin dose before and after the training intervention. This would be useful 
to determine whether there is a change in insulin sensitivity as reduced insulin dosage is 
associated with decreased risk of cardiovascular complications in people with type 1 
diabetes41,42. 
In summary, this is the first study to demonstrate that six weeks of HIT leads to 
comparable improvements in V& O2peak and arterial stiffness to MICT. HIT though may be the 
preferred exercise approach, as blood glucose remains stable during HIT, but falls 
substantially during MICT. We therefore recommend that HIT in the fed state is a safe, 
effective, flexible and time-efficient form of exercise for people with type 1 diabetes. 
Registration 
This study was registered as a clinical trial retrospectively in accordance with journal policy. 
ClinicalTrials.gov ID: NCT03544684. 
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Figure 1 – Effect of six weeks of high intensity interval training (HIT) and moderate 
intensity continuous training (MICT) on V& O2peak. (A) Shows the mean responses and (B) 
shows individual responses in V& O2peak with training. *Indicates a significant difference from 
baseline (P<0.05).  
Figure 2 - Change in blood glucose following exercise in the fed state. Finger prick blood 
glucose concentrations were recorded immediately before and after exercise. As such, over 
the course of the six weeks of training we gathered pre and post exercise blood glucose 
concentrations from a total of 108 MICT training sessions and 87 HIT sessions in the fed 
state (86% and 69% of total possible sessions, respectively). Mean change in blood glucose 
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concentration (A) and average change in blood glucose concentration during HIT and MICT 
over the 6 week training period (B). *Denotes a significant change from baseline (P<0.05). 
Table 1 - General characteristics 
 HIT MICT 
 Pre Post Pre Post 
Age (years) 29 ± 3 - 29 ± 5 - 
Sex 5M/2F - 5M/2F - 
Duration of T1D (years) 13 ± 3 - 9 ± 2 - 
Mass (kg) 90.0 ± 4.8 89.8 ± 4.8 76.7 ± 5.4 76.3 ± 5.3 
BMI (kg·m-2) 29.2 ± 1.2 29.2 ± 1.2 25.3 ± 1.2 25.2 ± 1.2 
V& O2peak (ml·kg-
1
·min-1) 
35.6 ± 2.6 40.5 ± 2.6* 32.1 ± 2.6 36.9 ± 3.2* 
V& O2peak (L/min-1) 3.2 ± 0.3 3.7 ± 0.3* 2.5 ± 0.3 2.9 ± 0.4* 
Wmax (W) 245 ± 16 277 ± 19* 202 ± 22 231 ± 24* 
SBP (mmHg) 121 ± 3 119 ± 4 123 ± 4 122 ± 4 
DBP (mmHg) 65 ± 3 63 ± 3 70 ± 5 68 ± 4 
MAP (mmHg) 84 ± 3 82 ± 2 87 ± 4 86 ± 3 
aPWV (m/s) 6.1 ± 0.5 5.4 ± 0.7* 6.1 ± 0.4 5.4 ± 0.4* 
Cholesterol (mmol/L) 5.07 ± 0.29 5.12 ± 0.35 4.81 ± 0.41 4.93 ± 0.41 
Triglycerides (mmol/L) 0.94 ± 0.09 1.03 ± 0.25 0.70 ± 0.04 0.65 ± 0.06 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial 
pressure; aPWV = arterial pulse wave velocity. Data are presented as mean ± SEM. *Denotes a significant 
change from pre-training to post-training (P<0.05). 
Table 2 - Summary of continuous glucose monitor data  
 
HIT MICT 
 
Pre Post Pre Post 
24h period     
Mean glucose (mmol/L) 9.3±0.3 9.5±1.0 9.2±0.6 8.6±0.7 
CV (%) 42.6±3.6 38.2±2.6 37.9±3.6 36.9±4.0 
Time in level 1 hypoglycaemia (%) 6.1±2.6 5.4±3.1 3.4±1.5 2.8±1.9 
Time in level 2 hypoglycaemia (%) 0.2±0.2 0.5±0.3 0.9±0.5 0.0±0.0 
Time in range (%) 56.7±3.1 56.4±7.8 59.3±5.8 68.2±7.7 
Time in hyperglycaemia  (%) 37.0±2.0 37.7±8.9 36.3±6.5 28.9±8.5 
Incidence of level 1 hypoglycaemia 1.8±0.6 1.2±0.5 0.9±0.5 1.4±0.6 
Incidence of level 2 hypoglycaemia 0.2±0.2 0.2±0.2 0.4±0.2 0.1±0.1 
Incidence of hyperglycaemia 3.0±0.5 2.8±0.5 3.2±0.5 2.5±0.5 
Nocturnal period     
Mean glucose (mmol/L) 8.8±1.3 11.7±2.0 8.0±1.2 7.4±1.1 
CV (%) 23.2±5.9 19.5±9.1 29.1±7.2 22.2±6.2 
Time in level 1 hypoglycaemia (%) 9.3±9.0 3.0±2.0 7.6±5.0 4.9±4.9 
Time in level 2 hypoglycaemia (%) 0.0±0.0 1.2±1.2 3.2±2.0 0.0±0.0 
Time in range (%) 57.4±15.5 32.6±14.3* 60.0±15.4 71.3±16.5 
Time in hyperglycaemia  (%) 33.3±16.7 63.0±16.3* 28.5±15.9 23.6±15.8 
Incidence of level 1 hypoglycaemia 0.5±0.2 0.3±0.2 0.3±0.2 0.1±0.1 
Incidence of level 2 hypoglycaemia 0.0±0.0 0.2±0.2 0.3±0.2 0.0±0.0 
Incidence of hyperglycaemia 0.5±0.2 0.8±0.2 0.5±0.2 0.3±0.2 
The 24h period was defined as 08:00-08:00h and nocturnal period as 24:00-06:00h. Level 1 hypoglycaemia 
(≤3.9 mmol/L), level 2 (severe) hypoglycaemia (≤2.9 mmol/L), target range (3.9-10 mmol/L) and 
hyperglycaemia (≥10 mmol/L). There were no differences in any of the variables with training (P>0.05). 
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